However, meta-analysis by Mandal et al. (2014) of 13 case-control studies (including 3,087 cases and 3,599 controls) reported the likely association of the XPD Lys751Gln polymorphism with the risk of development of cancer in Indian population. This evidence concerns the gene ERCC2 and cancer.